Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Overview of attention for article published in The Lancet, July 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
policy: 3 policy sources
twitter: 8 X users
facebook: 2 Facebook pages

reddit: 2 Redditors
f1000: 1 research highlight platform
guideline: 5 clinical guideline sources

Readers on

mendeley: 452 Mendeley

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 9,163 followers.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48... http://t.co/6y90Ledz0c

[Articles] Dolutegravir versus raltegravir in antiretroviral-experienced, ... http://t.co/lTLtKNbHEN

@martini_seco http://t.co/gV2D97PZfx

SAILING study:Dolutegravir in comb w superior to raltegravir in tx experienced integrase inhibitor-naive patients http://t.co/kfrvlZp3Re

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.